| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-10,268.3550 | -10,484.3150 | -9,166.7620 | -6,519.2680 | -2,139.0650 |
|
Research and Development Expenses
|
-18,965.9150 | -21,817.0720 | -18,798.3430 | -8,438.4990 | -1,336.4690 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | -- | 0 |
| Other Income/Expense, Operating
|
8.7260 | 4,006.5100 | 9,737.9740 | 7,144.8720 | 0 |
|
Operating Income/Expenses
|
-29,225.5440 | -28,294.8770 | -18,227.1310 | -7,812.8950 | -3,475.5340 |
|
Total Operating Profit/Loss
|
-29,225.5440 | -28,294.8770 | -18,227.1310 | -7,812.8950 | -3,475.5340 |
| Total Net Finance Income/Expense
|
703.7110 | 1,336.8370 | 1,937.4270 | 219.4300 | 61.6390 |
| Irregular Income/Expenses
|
-- | -- | -- | -- | 0 |
|
Other Income/Expense, Non-Operating
|
3.2980 | -8.3270 | -0.9910 | 5,421.5920 | -2,389.1520 |
|
Non-Operating Income/Expenses, Total
|
707.0090 | 1,328.5100 | 1,936.4360 | 5,641.0220 | -2,327.5130 |
|
Pretax Income
|
-28,518.5350 | -26,966.3670 | -16,290.6950 | -2,171.8730 | -5,803.0470 |
|
Provision for Income Tax
|
-- | -- | -- | -- | 0 |
|
Net Income from Continuing Operations
|
-28,518.5350 | -26,966.3670 | -16,290.6950 | -2,171.8730 | -5,803.0470 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-28,518.5350 | -26,966.3670 | -16,290.6950 | -2,171.8730 | -5,803.0470 |
|
Net Income after Non-Controlling/Minority Interests
|
-28,518.5350 | -26,966.3670 | -16,290.6950 | -2,171.8730 | -5,803.0470 |
|
Net Income Available to Common Stockholders
|
-28,518.5350 | -26,966.3670 | -16,290.6950 | -2,171.8730 | -5,803.0470 |
|
Dilution to Earnings
|
0 | -- | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
-28,518.5350 | -26,966.3670 | -16,290.6950 | -2,171.8730 | -5,803.0470 |
| Basic EPS
|
-2.65 | -2.98 | -2.02 | -0.82 | -11.20 |
| Diluted EPS
|
-2.65 | -2.98 | -2.02 | -0.82 | -11.20 |
|
Basic Weighted Average Shares Outstanding
|
10,985.3430 | 9,041.7600 | 8,073.1550 | 2,661.4160 | 518.1400 |
|
Diluted Weighted Average Shares Outstanding
|
10,985.3430 | 9,041.7600 | 8,073.1550 | 2,661.4160 | 518.1400 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-29,222.2460 | -28,303.2040 | -18,228.1220 | -2,391.3030 | -5,864.6860 |
|
EBITDA
|
-29,222.2460 | -28,303.2040 | -18,228.1220 | -2,391.3030 | -5,864.6860 |
|
Normalized EBITDA
|
-27,904.5950 | -26,854.5700 | -16,822.4000 | -7,407.9220 | -3,141.8510 |
|
Normalized Income
|
-27,200.8840 | -25,517.7330 | -14,884.9730 | -7,188.4920 | -3,080.2120 |
|
Total Unusual Items
|
1,317.6510 | 1,448.6340 | 1,405.7220 | -5,016.6190 | 2,722.8350 |
|
Total Unusual Items Excluding Goodwill
|
1,317.6510 | 1,448.6340 | 1,405.7220 | -5,016.6190 | 2,722.8350 |
12/31/2022 - 5/23/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade